Johnson Pharmacare Ltd
₹ 0.52
-1.89%
08 Jun
- close price
About
Incorporated in 1994, Johnson Pharmacare Ltd. (formerly Robinson Worldwide Trade Ltd) is involved in trading business and provides business services.
Key Points
- Market Cap ₹ 28.6 Cr.
- Current Price ₹ 0.52
- High / Low ₹ 0.93 / 0.47
- Stock P/E
- Book Value ₹ 0.01
- Dividend Yield 0.00 %
- ROCE -105 %
- ROE -146 %
- Face Value ₹ 1.00
Pros
Cons
- Stock is trading at 65.0 times its book value
- Company has low interest coverage ratio.
- Company has a low return on equity of -29.6% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | 0 | 0 | 0 | 1 | 0 | 1 | 3 | 3 | 0 | 0 | 0 | |
| 0 | 0 | 0 | 0 | 1 | 0 | 1 | 3 | 2 | 0 | 0 | 43 | |
| Operating Profit | -0 | -0 | -0 | -0 | -0 | -0 | 0 | 0 | 0 | -0 | -0 | -43 |
| OPM % | -1% | 0% | 4% | 9% | ||||||||
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2 | 0 | -0 | -13 | |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | -0 | -0 | -0 | -0 | -0 | -0 | 0 | 0 | -1 | -0 | -1 | -56 |
| Tax % | 0% | 0% | 0% | 0% | 0% | 0% | 31% | -3% | 0% | 0% | 0% | |
| -0 | -0 | -0 | -0 | -0 | -0 | 0 | 0 | -1 | -0 | -1 | -56 | |
| EPS in Rs | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | 0.00 | 0.00 | -0.02 | -0.00 | -0.01 | -1.01 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -16484% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | 19% |
| 3 Years: | 1% |
| 1 Year: | -42% |
| Return on Equity | |
|---|---|
| 10 Years: | -8% |
| 5 Years: | -16% |
| 3 Years: | -30% |
| Last Year: | -146% |
Balance Sheet
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 55 | 55 | 55 | 55 | 55 |
| Reserves | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 3 | 2 | 2 | 1 | -55 |
| 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 2 | 2 | 1 | 21 | |
| 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 0 | |
| Total Liabilities | 60 | 59 | 59 | 60 | 60 | 59 | 59 | 60 | 60 | 60 | 58 | 22 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 54 | 43 | 54 | 54 | 53 | 52 | 52 | 54 | 46 | 46 | 42 | 20 |
| 6 | 16 | 5 | 6 | 7 | 7 | 7 | 6 | 14 | 14 | 16 | 2 | |
| Total Assets | 60 | 59 | 59 | 60 | 60 | 59 | 59 | 60 | 60 | 60 | 58 | 22 |
Cash Flows
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 8 | -11 | 11 | -1 | -1 | 0 | -0 | 5 | -0 | -0 | -2 | -57 | |
| 10 | 11 | -11 | -0 | 1 | 1 | 0 | -5 | -1 | 0 | 3 | 58 | |
| 2 | 0 | 0 | 1 | 0 | -1 | 0 | -0 | 1 | 0 | -1 | -0 | |
| Net Cash Flow | 21 | 0 | 0 | -0 | -0 | -0 | -0 | -0 | -0 | 0 | 0 | -0 |
| Free Cash Flow | 8 | -11 | 11 | -1 | -1 | 0 | -0 | 5 | -0 | -0 | -2 | -57 |
| CFO/OP | -41,350% | 8,385% | -8,200% | 1,417% | 9,300% | -189% | 3,800% | -200% | 25% | 764% | 134% |
Ratios
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 365 | 807 | 118 | 0 | ||||||||
| Inventory Days | 0 | 0 | 0 | |||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 365 | 807 | 118 | 0 | ||||||||
| Working Capital Days | 1,932 | 2,267 | -9 | -141 | ||||||||
| ROCE % | -0% | -0% | -0% | -0% | -0% | -0% | 0% | 0% | 0% | -0% | -0% | -105% |
Insights
In beta| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|
| Investments held (Non-Current & Current) INR Lakhs |
|
||||||
| Loans Given to Others INR Lakhs |
|||||||
| Revenue from Operations (Operational Activity Status) INR |
|||||||
Requires Premium
Requires Premium
Extracted by Screener AI
Documents
Announcements
-
Outcome Of Meeting Of Board Held On Wednesday, 27Th May, 2026 At Pursuant To Regulation 30 Of The
SEBI (LODR) Regulations, 2015.
1 Jun - Board approved FY26 audited results; noted resignations of two directors effective 17 Apr 2026, with qualified audit opinion.
-
Compliances-Reg.24(A)-Annual Secretarial Compliance
30 May - Annual Secretarial Compliance Report for year ended March 31, 2026 notes website, SDD and RPT disclosure gaps.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
28 May - Submission of Extract of Newspaper Publication of Audited (Standalone) Financial Results for the quarter and year ended on 31st March 2026
-
Disclosure Of Related Party Transaction Pursuant To Regulation 23(9) Of SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015.
27 May - Disclosed nil related party transactions for year ended 31 March 2026.
-
Submission Of Audited Financial Results Of (JOHNSON PHARMACARE LTD) For The Quarter
And Financial Year Ended On March 31St, 2026 Along With Audited Report Thereon
27 May - FY26 audited results submitted; auditors note ₹11,123.52 lakh cash loss and non-IND AS compliance.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Services Offered:[1]
Company used to provide commercial services like purchase and sales of various good and services. Company also buys, trades, and sells shares and investments.